VOYA Investment Management
ITOS

VOYA Investment Management’s iTeos Therapeutics ITOS Stock Holding History

VOYA Investment Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,312
Closed -$277K – 2872
2024
Q1 		$277K Sell
20,312
-1,872
-8% -$20.4K ﹤0.01% 2287
2023
Q4 		$243K Hold
22,184
– – ﹤0.01% 2468
2023
Q3 		$243K Buy
22,184
+409
+2% +$5.23K ﹤0.01% 2428
2023
Q2 		$288K Buy
+21,775
New +$310K ﹤0.01% 2388
2022
Q2 		– Sell
-7,983
Closed -$257K – 2832
2022
Q1 		$257K Hold
7,983
– – ﹤0.01% 2245
2021
Q4 		$372K Sell
7,983
-308
-4% -$10.3K ﹤0.01% 2189
2021
Q3 		$224K Hold
8,291
– – ﹤0.01% 2505
2021
Q2 		$213K Hold
8,291
– – ﹤0.01% 2567
2021
Q1 		$283K Buy
+8,291
New +$300K ﹤0.01% 2343

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VOYA Investment Management's ITOS Position: Q2 2024 in Review

VOYA Investment Management sold out of iTeos Therapeutics (ITOS) in Q2 2024, closing a stake of 20,312 shares — an estimated $277K sold.

VOYA Investment Management first reported a position in ITOS in Q1 2021 and held it in 9 quarters. The position peaked at $372K in Q4 2021. 137 funds tracked by Wall St. Rank hold ITOS as of Q2 2024.

  • VOYA Investment Management reported no remaining iTeos Therapeutics position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 20,312 iTeos Therapeutics shares in Q2 2024, an estimated $277K.
  • VOYA Investment Management first reported a position in iTeos Therapeutics in Q1 2021 and held it in 9 quarters.
  • VOYA Investment Management's iTeos Therapeutics position peaked at $372K in Q4 2021.
  • 137 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.